<DOC>
	<DOCNO>NCT02701881</DOCNO>
	<brief_summary>- Prospective , randomize , control , multi-center study - A total 220 subject long femoropopliteal lesion include accord inclusion exclusion criterion . - Patients randomize 1:1 manner long stenting group versus short stenting group . treat Zilver PTX long femoropopliteal lesion - Patients follow clinically 1 year procedure . - Image study follow-up ( Duplex US CT angiography ) perform 1 year .</brief_summary>
	<brief_title>Comparison PrimAry Long Versus Short Coverage With Drug-Eluting Stents Long FemoRopopliteal Artery DiseasE ( PARADE II ) : Investigator-initiated Clinical Study</brief_title>
	<detailed_description />
	<criteria>Clinical criterion : 1 . Age 19 year old 2 . Symptomatic peripheral artery disease : 1 . Moderate severe claudication ( Rutherford category 2 3 ) 2 . Critical limb ischemia ( Rutherford category 4 5 ) 3 . Patients sign informed consent Anatomical criterion : 1 . Target lesion length â‰¥150 mm angiographic estimation 2 . Stenosis 50 % femoropopliteal artery 3 . At least one patent ( le 50 percent stenosed ) tibioperoneal runoff vessel . A . Clinical criterion 1 . Acute critical limb ischemia 2 . Severe critical limb ischemia ( Rutherford category 6 ) 3 . Major bleed history within prior 2 month 4 . Known hypersensitivity contraindication follow medication : heparin , aspirin , clopidogrel contrast agent 5 . Age &gt; 85 year 6 . Severe hepatic dysfunction ( &gt; 3 time normal reference value ) 7 . Significant renal dysfunction ( Serum creatinine &gt; 2.0 mg/dl 8 . Significant leucopenia , neutropenia , thrombocytopenia , anemia , know bleed diathesis 9 . LVEF &lt; 40 % clinically overt congestive heart failure 10 . Pregnant woman woman potential childbearing 11 . Life expectancy &lt; 1 year due comorbidity Angiographic criterion 1 . Previous bypass surgery stenting superficial femoral artery 2 . Untreated inflow disease ipsilateral pelvic artery ( 50 % stenosis occlusion 3 . Popliteal artery stenosis &gt; 50 % P2 P3 segment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Femoropopliteal Artery</keyword>
	<keyword>Drug-eluting Stent</keyword>
	<keyword>Endovascular Therapy</keyword>
</DOC>